Jerome Edelson1, Jessica E Basso1, Don C Rockey2. 1. Department of Gastroenterology and Hepatology, Brooke Army Medical Center, Fort Sam Houston, Texas. 2. Digestive Disease Research Center, Medical University of South Carolina, Charleston, South Carolina, USA.
Abstract
PURPOSE OF REVIEW: This article reviews the most recent studies regarding the management of acute esophageal variceal haemorrhage. RECENT FINDINGS: New randomized control trials and meta-analyses confirmed the role of early transjugular intrahepatic portosystemic shunt (TIPS) in the management of acute variceal haemorrhage in Child-Pugh C (10-13) and B patients with active bleeding. A recent randomized controlled trial focused on the duration of vasoactive therapy showed no difference between 2 and 5 days of octreotide. A randomized trial showed decreased use of blood products for the correction of coagulopathy using a thromboelastography-guided approach (vs. conventional parameters) as well as decreased bleeding rates when compared with standard of care. A meta-analysis found that for rescue of variceal bleeding, self-expanding metallic stents were more efficacious and safer than balloon tamponade. In addition, studies showed that Child-Pugh C patients and those with hepatic vein pressure gradient more than 20 were at the highest risk of treatment failure, while model for end-stage liver disease was highly predictive of in-hospital mortality. SUMMARY: In patients with severe coagulopathy and uncontrolled bleeding, TEG-based transfusion strategies are recommended. Antibiotics should be used for all cirrhotic patients presenting with upper gastrointestinal bleeding, but should be tailored in accordance to local resistance patterns. Early TIPS for high-risk patients has been shown to have a significant survival benefit. Certain aspects of the management of variceal bleeding remain poorly studied such as the role of early TIPS in Child-B patients as well as strategies for rescue therapy in patients who are not TIPS candidates, and require further investigation.
PURPOSE OF REVIEW: This article reviews the most recent studies regarding the management of acute esophageal variceal haemorrhage. RECENT FINDINGS: New randomized control trials and meta-analyses confirmed the role of early transjugular intrahepatic portosystemic shunt (TIPS) in the management of acute variceal haemorrhage in Child-Pugh C (10-13) and B patients with active bleeding. A recent randomized controlled trial focused on the duration of vasoactive therapy showed no difference between 2 and 5 days of octreotide. A randomized trial showed decreased use of blood products for the correction of coagulopathy using a thromboelastography-guided approach (vs. conventional parameters) as well as decreased bleeding rates when compared with standard of care. A meta-analysis found that for rescue of variceal bleeding, self-expanding metallic stents were more efficacious and safer than balloon tamponade. In addition, studies showed that Child-Pugh C patients and those with hepatic vein pressure gradient more than 20 were at the highest risk of treatment failure, while model for end-stage liver disease was highly predictive of in-hospital mortality. SUMMARY: In patients with severe coagulopathy and uncontrolled bleeding, TEG-based transfusion strategies are recommended. Antibiotics should be used for all cirrhotic patients presenting with upper gastrointestinal bleeding, but should be tailored in accordance to local resistance patterns. Early TIPS for high-risk patients has been shown to have a significant survival benefit. Certain aspects of the management of variceal bleeding remain poorly studied such as the role of early TIPS in Child-B patients as well as strategies for rescue therapy in patients who are not TIPS candidates, and require further investigation.
Authors: Javier Fernández; Verónica Prado; Jonel Trebicka; Alex Amoros; Thierry Gustot; Reiner Wiest; Carme Deulofeu; Elisabet Garcia; Juan Acevedo; Valentin Fuhrmann; François Durand; Cristina Sánchez; Maria Papp; Paolo Caraceni; Victor Vargas; Rafael Bañares; Salvatore Piano; Martin Janicko; Agustin Albillos; Carlo Alessandria; German Soriano; Tania M Welzel; Wim Laleman; Alexander Gerbes; Andrea De Gottardi; Manuela Merli; Minneke Coenraad; Faouzi Saliba; Marco Pavesi; Rajiv Jalan; Pere Ginès; Paolo Angeli; Vicente Arroyo Journal: J Hepatol Date: 2018-11-02 Impact factor: 25.083
Authors: N C Chavez-Tapia; T Barrientos-Gutierrez; F Tellez-Avila; K Soares-Weiser; N Mendez-Sanchez; C Gluud; M Uribe Journal: Aliment Pharmacol Ther Date: 2011-06-27 Impact factor: 8.171
Authors: Juan G Abraldes; Cándid Villanueva; Rafael Bañares; Carles Aracil; Maria Vega Catalina; Juan Carlos Garci A-Pagán; Jaime Bosch Journal: J Hepatol Date: 2007-11-26 Impact factor: 25.083
Authors: Marcus Robertson; Jonathan Ng; Walid Abu Shawish; Adrian Swaine; Gillian Skardoon; Andrew Huynh; Sheetal Deshpande; Zi Yi Low; William Sievert; Peter Angus Journal: Dig Endosc Date: 2019-12-20 Impact factor: 7.559
Authors: Ja Yun Choi; Yun Won Jo; Sang Soo Lee; Wan Soo Kim; Hye Won Oh; Cha Young Kim; Eun Young Yun; Jin Joo Kim; Jae Min Lee; Hong Jun Kim; Hyun Jin Kim; Tae Hyo Kim; Woon Tae Jung; Ok Jae Lee; Rock Bum Kim Journal: Korean J Intern Med Date: 2017-11-10 Impact factor: 2.884